Shanghai Biopharmaleader co.,ltd

Date: 18th July 2016
Cediranib CAS:288383-20-0
If you are going to consult the information about 288383-20-0 from one of the leading 288383-20-0 manufacturers and suppliers in China, Biopharmaleader Co.,Ltd is always at your service.Product InformationCAS NO.288383-20-0?Product NameCediranibSynonymsAZD-2171FormulaC25H27FN4O3Molecular Weight450.51Spec / Purity98%minSupply CapacityDetailsCediranib (AZD-2171) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. On 8 March 2010, AstraZeneca issued a press-release stating that cediranib had failed Phase III clinical trials for use in first-line metastatic colorectal cancer when it was compared clinically with the market-leader bevacizumab. As of November 2012, it was being assessed in double-blind studies for the treatment of methylated Glioblastoma Multiforme at the University of Washington Medical Center.
Latest News
Contact Information



Building 11, NO. 3802 ShenGang Rd, Xinfei Corporation Home, SongJiang District, Shanghai,201611, China.
Shanghai, 201611


Contact Form